Sudden irreversible hearing loss post COVID-19

BMJ Case Rep. 2020 Oct 13;13(11):e238419. doi: 10.1136/bcr-2020-238419.

Abstract

Sudden onset sensorineural hearing loss (SSNHL) is frequently seen by otolaryngologists. The exact pathophysiology of the disease is still unknown, with the most likely causative factor being following a viral infection. Immediate steroids are the best treatment to improve prognosis. Despite a plethora of papers in the literature describing SSNHL, there are only a few reported cases of hearing loss following COVID-19, none of which have been reported in the UK. This paper presents the first UK case of SSNHL following COVID-19. Physical examination and imaging excluded any other cause of hearing loss. A literature review showed that four other cases have been previously described. Hearing loss can be a significant cause of morbidity and can easily be missed in the intensive care setting. Being aware and screening for SSNHL following COVID-19 enables an early course of steroids, which offers the best chance of recovering hearing.

Keywords: disease and health outcomes; ear; global Health; nose and throat/otolaryngology; otolaryngology / ENT.

Publication types

  • Case Reports

MeSH terms

  • Administration, Oral
  • Betacoronavirus*
  • COVID-19
  • Coronavirus Infections / complications*
  • Glucocorticoids / administration & dosage
  • Glucocorticoids / therapeutic use
  • Hearing Loss, Sudden / complications*
  • Hearing Loss, Sudden / diagnosis
  • Hearing Loss, Sudden / drug therapy*
  • Humans
  • Injections
  • Male
  • Methylprednisolone Hemisuccinate / administration & dosage
  • Methylprednisolone Hemisuccinate / therapeutic use*
  • Middle Aged
  • Pandemics
  • Pneumonia, Viral / complications*
  • Prednisolone / administration & dosage
  • Prednisolone / therapeutic use*
  • SARS-CoV-2

Substances

  • Glucocorticoids
  • Methylprednisolone Hemisuccinate
  • Prednisolone